In the CAD population, borderline significance was noted between RARRES2 polymorphisms and chemerin levels, whereas high chemerin levels were associated with obesity, female sex, diabetes mellitus, hypertension, current smoking, high platelet and leukocyte counts, anemia, impaired renal function, high C-reactive protein (CRP) levels, and multi-vessel disease.
← all excerpts
Circulating Chemerin Levels, but not the <i>RARRES2</i> Polymorphisms, Predict the Long-Term Outcome of Angiographically Confirmed Coronary Artery Disease.
1
—
—